restenosis therapeutics (Cerylid)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namerestenosis therapeutics (Cerylid)
Drug Alias Namerestenosis therapy (Kinacia)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein kinases inhibitors
TargetsProtein kinases
Therapy Area/IndicationsCoronary Restenosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKinacia Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKinacia Pty LtdCerylid Biosciences
Active IndicationsN/A
Inactive IndicationsCoronary Restenosis

Other Information

ATC CodeN/A
Related LinksN/A